Generation Drugs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generation drugs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generation Drugs Today - Breaking & Trending Today

Biopharma Companies With COVID-19 Treatments See $10 Billion Market in 2021


In the second of three articles, we assess the market for COVID-19 treatments. (Click here for our outlook for coronavirus vaccines and distribution.) The final article will cover prospects for the companies involved.
As with most viruses, developing COVID-19 treatments has been difficult, but several drugs have shown strong enough efficacy to gain regulatory support. Historically, one of the best ways to control viruses is through vaccines, and we believe the vaccines emerging will significantly lower the need for COVID-19 treatments by 2023 and beyond. Nevertheless, treatments are in high demand currently and are likely to remain so through 2021 and into 2022. Currently, several drugs are used to treat COVID-19, but most have limitations in efficacy and timing of use relative to the disease progression. ....

United States , Merck Ridgeback , Lilly Olumiant , Regeneron Roche , Glaxosmithkline Vir , Eli Lilly , Centers For Disease , Us Department Of Health , Human Services , National Institutes Of Health , World Health Organization , Drug Administration , Duke Margolis Center , Atea Pharmaceuticals , Infectious Diseases Society Of America , Poor Long Term , Disease Control , National Institutes , Infectious Diseases Society , Treatment Market Should Grow , Health Policy , Generation Antibody Treatments , Generation Drugs , ஒன்றுபட்டது மாநிலங்களில் , மெர்க் ரிட்ஜ்பேக் , கிளாக்சோஸ்மித்க்லைன் வீர் ,